These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Hypotensive response to atrial natriuretic factor in conscious chronic pulmonary hypertensive rats. Lee KC; Lappe RW Eur J Pharmacol; 1988 Dec; 158(1-2):153-6. PubMed ID: 2975606 [TBL] [Abstract][Full Text] [Related]
23. alpha-Difluoromethylornithine, an inhibitor of polyamine synthesis, attenuates monocrotaline-induced pulmonary vascular hyperresponsiveness in isolated perfused rat lungs. Gillespie MN; Dyer KK; Olson JW; O'Connor WN; Altiere RJ Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):365-78. PubMed ID: 3936139 [TBL] [Abstract][Full Text] [Related]
24. Oral sildenafil prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats. Liu H; Liu ZY; Guan Q Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):608-13. PubMed ID: 17670742 [TBL] [Abstract][Full Text] [Related]
25. [Effect of hydralazine on the pulmonary arterial hypertension in monocrotaline induced cor pulmonale in Macacus rhesus]. Sun BT Zhonghua Jie He He Hu Xi Za Zhi; 1987 Aug; 10(4):229-30, 255, 15. PubMed ID: 3125990 [No Abstract] [Full Text] [Related]
27. [Experimental glomerulopathy induced by monocrotaline in rats]. Yoshida M; Kimura T; Fukutomi K; Maemura T; Nagasawa T Nihon Jinzo Gakkai Shi; 1986 Feb; 28(2):109-14. PubMed ID: 3090323 [No Abstract] [Full Text] [Related]
28. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats. Lu J; Shimpo H; Shimamoto A; Chong AJ; Hampton CR; Spring DJ; Yada M; Takao M; Onoda K; Yada I; Pohlman TH; Verrier ED J Thorac Cardiovasc Surg; 2004 Dec; 128(6):850-9. PubMed ID: 15573069 [TBL] [Abstract][Full Text] [Related]
29. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering. Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214 [TBL] [Abstract][Full Text] [Related]
30. Elevated serum copper concentration in monocrotaline pyrrole treated rats with pulmonary hypertension. Ganey PE; Roth RA Biochem Pharmacol; 1987 Oct; 36(20):3535-7. PubMed ID: 3675611 [No Abstract] [Full Text] [Related]
31. Tetrandrine inhibited chronic "inflammatory" pulmonary hypertension in rats. Wang HL; Zhang XH; Jin X; Xing J; Zhang DR Zhongguo Yao Li Xue Bao; 1997 Sep; 18(5):401-4. PubMed ID: 10322926 [TBL] [Abstract][Full Text] [Related]
32. Monocrotaline-induced pulmonary vascular disease after contralateral lung transplantation in the rat. Kawaguchi AT; Kawashima Y; Ishibashi-Ueda H; Mizuta T; Kitoh Y; Kunieda T J Heart Lung Transplant; 1993; 12(2):325-8; discussion 328-9. PubMed ID: 8476905 [TBL] [Abstract][Full Text] [Related]
33. Potassium dependent relaxation of isolated pulmonary artery segments following ingestion of monocrotaline. Shubat PJ; Huxtable RJ Proc West Pharmacol Soc; 1988; 31():313-5. PubMed ID: 3145503 [No Abstract] [Full Text] [Related]
34. [Effects of prostaglandin E1 (PGE1) on pulmonary hypertension and lung vascular remodeling in a rat monocrotaline model of human pulmonary hypertension]. Ono S; Tanita T; Hoshikawa Y; Song C; Maeda S; Tabata T; Noda M; Ueda S; Ashino Y; Fujimura S Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Aug; 33(8):862-7. PubMed ID: 7474567 [TBL] [Abstract][Full Text] [Related]
35. Effects of single-lung transplantation on chemically induced pulmonary hypertension in the rat. Kawaguchi AT; Mizuta T; Matsuda H; Shirakura R; Nakahara K; Tanaka H; Kawashima Y Transplant Proc; 1991 Feb; 23(1 Pt 2):1220-1. PubMed ID: 1824891 [No Abstract] [Full Text] [Related]
36. Pulmonary vascular responses induced by the pyrrolizidine alkaloid, monocrotaline, in rats. Shubat PJ; Banner W; Huxtable RJ Toxicon; 1987; 25(9):995-1002. PubMed ID: 3124302 [TBL] [Abstract][Full Text] [Related]
37. Pulmonary hypertension due to monocrotaline pyrrole is reduced by moderate thrombocytopenia. Ganey PE; Sprugel KH; White SM; Wagner JG; Roth RA Am J Physiol; 1988 Nov; 255(5 Pt 2):H1165-72. PubMed ID: 3189578 [TBL] [Abstract][Full Text] [Related]
38. Effects of phenobarbitone, cinnarizine, and zoxazolamine on the development of right ventricular hypertrophy and hypertensive pulmonary vascular disease in rats treated with monocrotaline. Kay JM; Smith P; Heath D; Will JA Cardiovasc Res; 1976 Mar; 10(2):200-5. PubMed ID: 132989 [TBL] [Abstract][Full Text] [Related]
39. Pulmonary mechanical, ventilatory, and gas exchange abnormalities in rats with monocrotaline-induced pulmonary hypertension. Gillespie MN; Frederick WB; Altiere RJ; Olson JW; Kimmel EC Exp Lung Res; 1985; 8(2-3):191-9. PubMed ID: 3928341 [TBL] [Abstract][Full Text] [Related]